Philip Morris International (PM) Earnings: FY Adjusted EPS Confirmed Ahead of 2025 CAGNY Conference

Philip Morris International on Smartkarma

Analyst coverage of Philip Morris International on Smartkarma showcases various insights from Baptista Research analysts. In a research report titled “Philip Morris: Is This Tobacco Giant’s Pricing Power Strong Enough to Defy Declining Demand?” the analysts discuss PMI’s strong performance in 2024, emphasizing the company’s focus on smoke-free products like IQOS alongside resilient performance in combustible products. Despite regulatory challenges, PMI shows momentum in key markets like Japan and Europe.

Another report by Baptista Research, “Philip Morris International Inc.: These Are The 6 Biggest Factors Influencing Its Performance In 2025 & Beyond! – Major Drivers,” highlights PMI’s robust third-quarter results in 2024. The company achieved gains in traditional and smoke-free product categories, margin expansion, and growth in earnings per share, indicating strong strategic execution following a successful first half of the year.

A look at Philip Morris International Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Philip Morris International Inc. is positioned favorably for long-term success based on the Smartkarma Smart Scores analysis. With a high Resilience score of 5, the company is well-prepared to weather economic uncertainties and market fluctuations. This indicates its ability to maintain stable performance in the face of challenges.

Furthermore, the company’s strong Momentum score of 5 suggests that it is on a positive growth trajectory and has good potential for future growth. Combined with a solid Dividend score of 4, highlighting its consistent dividend payments, Philip Morris International presents an attractive investment opportunity for those seeking stable returns.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma